Amphetamine use as a risk factor for low-dose risperidone-induced acute dystonia: a case report.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  The Primary Care Companion For CNS Disorders

• Publication date

  2012-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.4088/PCC.12l01397PMID 23585993PMCID PMC3622532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Substance abuse and movement disorders

  2010cited by this paper
• From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics

  2010cited by this paper
• International consensus study of antipsychotic dosing.

  2010cited by this paper
• Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons.

  2010cited by this paper
• Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.

  2010cited by this paper
• Substance abuse is associated with increased extrapyramidal symptoms in schizophrenia: a meta-analysis.

  2009cited by this paper
• Cocaine Dependence and D2 Receptor Availability in the Functional Subdivisions of the Striatum: Relationship with Cocaine-Seeking Behavior

  2004cited by this paper
• Acute dystonia induced by drug treatment

  1999cited by this paper
• SPECT imaging of striatal dopamine release after amphetamine challenge.

  1995cited by this paper

• No citing papers are available for this paper.